Ricardo Lastra to Molecular Targeted Therapy
This is a "connection" page, showing publications Ricardo Lastra has written about Molecular Targeted Therapy.
Connection Strength
0.036
-
SPHK1 Is a Novel Target of Metformin in Ovarian Cancer. Mol Cancer Res. 2019 04; 17(4):870-881.
Score: 0.036
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.